Successful Cases
>> Cases

With deep understanding of imaging evaluation criteria, FAB provides all-round support to launch new drugs by means of involving in a number of projects to speed up the completion of evaluation process, to shorten the time of clinical trials, to support CDE meetings, to do research and collect data relying on excellent expert team, experience about excellent projects and operational management skills, and high-efficient execution. 

39 projects have been submitted to NMPA, and 27 projects have been successfully approved for marketing, such as Pyrotinib Maleate Tablets, Pralatrexate, Almonertinib Mesilate Tablets, etc.

Small Molecule


Medical Devices

Home Services Telephone Message